As of 2025-07-01, the Relative Valuation of Avidity Biosciences Inc (RNA) is (60.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.40 USD, the upside of Avidity Biosciences Inc based on Relative Valuation is -313.6%.
The range of the Relative Valuation is (40.13) - (77.50) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.6x - 25.3x | 19.0x |
| Forward P/E multiples | 13.1x - 28.2x | 20.6x |
| Fair Price | (40.13) - (77.50) | (60.65) |
| Upside | -241.3% - -372.9% | -313.6% |
| Date | P/E |
| 2025-06-27 | -9.48 |
| 2025-06-26 | -9.74 |
| 2025-06-25 | -9.76 |
| 2025-06-24 | -9.75 |
| 2025-06-23 | -9.52 |
| 2025-06-20 | -9.57 |
| 2025-06-18 | -9.57 |
| 2025-06-17 | -9.59 |
| 2025-06-16 | -9.73 |
| 2025-06-13 | -10.24 |
| 2025-06-12 | -10.49 |
| 2025-06-11 | -10.45 |
| 2025-06-10 | -10.98 |
| 2025-06-09 | -10.66 |
| 2025-06-06 | -11.83 |
| 2025-06-05 | -11.62 |
| 2025-06-04 | -11.17 |
| 2025-06-03 | -11.23 |
| 2025-06-02 | -10.83 |
| 2025-05-30 | -10.11 |
| 2025-05-29 | -10.35 |
| 2025-05-28 | -10.09 |
| 2025-05-27 | -9.91 |
| 2025-05-23 | -9.98 |
| 2025-05-22 | -10.06 |
| 2025-05-21 | -10.00 |
| 2025-05-20 | -10.33 |
| 2025-05-19 | -9.87 |
| 2025-05-16 | -9.91 |
| 2025-05-15 | -9.46 |
| 2025-05-14 | -9.27 |
| 2025-05-13 | -9.75 |
| 2025-05-12 | -9.58 |
| 2025-05-09 | -9.10 |
| 2025-05-08 | -9.37 |
| 2025-05-07 | -8.54 |
| 2025-05-06 | -8.57 |
| 2025-05-05 | -10.54 |
| 2025-05-02 | -10.51 |
| 2025-05-01 | -10.67 |
| 2025-04-30 | -10.66 |
| 2025-04-29 | -10.50 |
| 2025-04-28 | -10.19 |
| 2025-04-25 | -10.07 |
| 2025-04-24 | -10.10 |
| 2025-04-23 | -10.02 |
| 2025-04-22 | -9.61 |
| 2025-04-21 | -9.31 |
| 2025-04-17 | -8.70 |
| 2025-04-16 | -8.41 |